DNAVEC

Welcome to the Brand page for “DNAVEC”, which is offered here for Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for x-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancer, critical limb ischemia, cystic fibrosis, retinitis pigmentosa, aids, influenza, and alzheimer's disease; preparations for gene therapy, introducing genes to human and animal cells, tissues, organs and living bodies, and cell growth media for medical purposes; vaccines; gene vaccines; rna vectors for introducing genes to human and animal cells, tissues, organs and living bodies, and cell growth media for medical use, for gene therapy;testing, inspection, research, or development of pharmaceuticals, cosmetics, or foodstuff; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing, inspection, research, or development of vaccines; testing, inspection, research, or development of recombinant proteins; medical, chemical, biochemical, biological and bacteriological research and functional analysis of genes or proteins; testing, inspection, or research related to technologies for manufacturing genetically engineered animals, plants, and vectors; testing, inspection, research, or development of vector technologies, medical and scientific research in the field of genetics and genetic engineering; testing, inspection, or research on agriculture, livestock breeding, or fisheries; testing, inspection, research, or development of chemicals for life science; testing or research on machines and instruments; computer software design, computer programming, or maintenance of computer software; rental of computers and rental of computer programs;.

Its status is currently believed to be active. Its class is unavailable. “DNAVEC” is believed to be currently owned by “ID Pharma Co., Ltd.”